Compounds > tuftsin
Page last updated: 2024-09-04

tuftsin and Cryptococcosis

tuftsin has been researched along with Cryptococcosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aljarbou, A; Khan, A; Khan, MA; Owais, M1
Khan, MA; Nasti, TH; Owais, M1
Khan, MA; Owais, M1

Other Studies

3 other study(ies) available for tuftsin and Cryptococcosis

ArticleYear
Immune stimulating and therapeutic potential of tuftsin-incorporated nystatin liposomes against Cryptococcus neoformans in leukopenic BALB/C mice.
    FEMS immunology and medical microbiology, 2012, Volume: 66, Issue:1

    Topics: Animals; Antifungal Agents; Brain; Cells, Cultured; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Immunologic Factors; Liposomes; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Nystatin; Survival Analysis; Treatment Outcome; Tuftsin

2012
Incorporation of amphotericin B in tuftsin-bearing liposomes showed enhanced efficacy against systemic cryptococcosis in leucopenic mice.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Cryptococcosis; Dose-Response Relationship, Drug; Drug Synergism; Immunologic Factors; Leukocytes; Leukopenia; Liposomes; Lung; Mice; Mice, Inbred BALB C; Tuftsin

2005
Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.
    Journal of drug targeting, 2005, Volume: 13, Issue:7

    Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Immunocompetence; Immunologic Factors; Liposomes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Tuftsin

2005